Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Treatment of Moderately
.
Show all posts
Showing posts with label
Treatment of Moderately
.
Show all posts
Tuesday, August 14, 2018
Pfizer Announces U.S. FDA Approves Xeljanz (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis
›
In continuation of my update on tofacitinib Pfizer Inc. announced that the United States (U.S.) Food and Drug Administration (FDA...
›
Home
View web version
